Clarity Wealth Advisors LLC Decreases Position in iShares Biotechnology ETF (NASDAQ:IBB)

Clarity Wealth Advisors LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 12,520 shares of the financial services provider’s stock after selling 1,309 shares during the period. Clarity Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,655,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Park Avenue Securities LLC acquired a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $218,000. Albion Financial Group UT increased its position in shares of iShares Biotechnology ETF by 0.3% during the third quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock worth $18,925,000 after acquiring an additional 356 shares during the last quarter. Valeo Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the third quarter worth about $206,000. CenterStar Asset Management LLC purchased a new position in iShares Biotechnology ETF in the third quarter valued at about $386,000. Finally, Martin Capital Advisors LLP grew its stake in iShares Biotechnology ETF by 1.0% during the 3rd quarter. Martin Capital Advisors LLP now owns 13,169 shares of the financial services provider’s stock valued at $1,918,000 after purchasing an additional 133 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 2.1 %

iShares Biotechnology ETF stock opened at $137.67 on Friday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The stock has a 50 day moving average of $136.22 and a 200-day moving average of $141.41.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.